PRESS RELEASE
News
-
-
-
-
-
-
-
PRESS RELEASE
Actor Pharmaceuticals and Megalabs become partners for the commercialization of Formycon’s Eylea® biosimilar FYB203 (aflibercept) for Australia and Latin America
Actor Pharmaceuticals and Megalabs to commercialize Formycon's Eylea biosimilar FYB203 in Australia and Latin America. Partnership agreements include upfront payments and royalties -
PRESS RELEASE
Formation Metals Closes $8.26M First Tranche of Its Private Placements, Fully Funding 20,000 Metre Drill Program at the Advanced N2 Gold Project
Formation Metals Inc. has closed an $8.26M private placement, fully funding a 20,000 metre drill program at N2 Gold Project. Company has working capital of $12.7M with zero debt -
-
